A novel theta-controlled vibrotactile brain-computer interface to treat chronic pain: a pilot study

Sci Rep. 2024 Feb 10;14(1):3433. doi: 10.1038/s41598-024-53261-3.

Abstract

Limitations in chronic pain therapies necessitate novel interventions that are effective, accessible, and safe. Brain-computer interfaces (BCIs) provide a promising modality for targeting neuropathology underlying chronic pain by converting recorded neural activity into perceivable outputs. Recent evidence suggests that increased frontal theta power (4-7 Hz) reflects pain relief from chronic and acute pain. Further studies have suggested that vibrotactile stimulation decreases pain intensity in experimental and clinical models. This longitudinal, non-randomized, open-label pilot study's objective was to reinforce frontal theta activity in six patients with chronic upper extremity pain using a novel vibrotactile neurofeedback BCI system. Patients increased their BCI performance, reflecting thought-driven control of neurofeedback, and showed a significant decrease in pain severity (1.29 ± 0.25 MAD, p = 0.03, q = 0.05) and pain interference (1.79 ± 1.10 MAD p = 0.03, q = 0.05) scores without any adverse events. Pain relief significantly correlated with frontal theta modulation. These findings highlight the potential of BCI-mediated cortico-sensory coupling of frontal theta with vibrotactile stimulation for alleviating chronic pain.

MeSH terms

  • Brain-Computer Interfaces*
  • Chronic Pain* / therapy
  • Electroencephalography
  • Humans
  • Longitudinal Studies
  • Neurofeedback*
  • Non-Randomized Controlled Trials as Topic
  • Pilot Projects